Skip to main content
Erschienen in: Psychiatric Quarterly 3/2010

01.09.2010 | Original Paper

Aggression in Borderline Personality Disorder

verfasst von: K. Látalová, J. Praško

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

This review examined aggressive behavior in Borderline Personality Disorder (BPD) and its management in adults. Aggression against self or against others is a core component of BPD. Impulsiveness is a clinical hallmark (as well as a DSM-IV-TR diagnostic criterion) of BPD, and aggressive acts by BPD patients are largely of the impulsive type. BPD has high comorbidity rates with substance use disorders, Bipolar Disorder, and Antisocial Personality Disorder; these conditions further elevate the risk for violence. Treatment of BDP includes psychodynamic, cognitive behavioral, schema therapy, dialectic behavioral, group and pharmacological interventions. Recent studies indicate that many medications, particularly atypical antipsychotics and anticonvulsants, may reduce impulsivity, affective lability as well as irritability and aggressive behavior. But there is still a lack of large, double blind, placebo controlled studies in this area.
Literatur
1.
Zurück zum Zitat Oquendo MA, Mann JJ: The biology of impulsivity and suicidality. Psychiatric Clinics of North America 23:11–25, 2000.CrossRefPubMed Oquendo MA, Mann JJ: The biology of impulsivity and suicidality. Psychiatric Clinics of North America 23:11–25, 2000.CrossRefPubMed
2.
Zurück zum Zitat Moyer KE: The Psychobiology of Aggression. New York, Harper & Row Publishers, 1976. Moyer KE: The Psychobiology of Aggression. New York, Harper & Row Publishers, 1976.
3.
Zurück zum Zitat Citrome L, Volavka J: Treatment of Violent Behavior. In: Tasman A, Kay J, Lieberman JA (Eds) Psychiatry, 2 edn. Chichester, John Wiley & Sons Ltd, 2003. Citrome L, Volavka J: Treatment of Violent Behavior. In: Tasman A, Kay J, Lieberman JA (Eds) Psychiatry, 2 edn. Chichester, John Wiley & Sons Ltd, 2003.
4.
Zurück zum Zitat Soloff PH, Meltzer CC, Becker C, et al.: Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Research: Neuroimaging Section 123:153–163, 2003.CrossRef Soloff PH, Meltzer CC, Becker C, et al.: Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Research: Neuroimaging Section 123:153–163, 2003.CrossRef
5.
Zurück zum Zitat Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al.: Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. Journal of Neuropsychiatry and Clinical Neurosciences 3:S44–S51, 1991.PubMed Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al.: Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. Journal of Neuropsychiatry and Clinical Neurosciences 3:S44–S51, 1991.PubMed
6.
Zurück zum Zitat Arntz A, van den HM, Cornelis J, et al.: Reliability and validity of the borderline personality disorder severity index. Journal of Personality Disorders 17:45–59, 2003. Arntz A, van den HM, Cornelis J, et al.: Reliability and validity of the borderline personality disorder severity index. Journal of Personality Disorders 17:45–59, 2003.
7.
Zurück zum Zitat Buss AH, Durkee A: An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 21:343–349, 1957.CrossRefPubMed Buss AH, Durkee A: An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 21:343–349, 1957.CrossRefPubMed
8.
Zurück zum Zitat Schwenkenmezger P, Hodapp V, Spielberger CD: The State-Trait Anger Expression Inventory. Goettingen, Huber, 1992. Schwenkenmezger P, Hodapp V, Spielberger CD: The State-Trait Anger Expression Inventory. Goettingen, Huber, 1992.
9.
Zurück zum Zitat Buss AH, Perry M: The aggression questionnaire. Journal of Personality and Social Psychology 63:452–459, 1992.CrossRefPubMed Buss AH, Perry M: The aggression questionnaire. Journal of Personality and Social Psychology 63:452–459, 1992.CrossRefPubMed
10.
Zurück zum Zitat Swanson JW, Holzer CE, Ganju VK, et al.: Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hospital and Community Psychiatry 41:761–770, 1990. Swanson JW, Holzer CE, Ganju VK, et al.: Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hospital and Community Psychiatry 41:761–770, 1990.
11.
Zurück zum Zitat Pulay AJ, Dawson DA, Hasin DS, et al.: Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry e1–e11, 2007. Pulay AJ, Dawson DA, Hasin DS, et al.: Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry e1–e11, 2007.
12.
Zurück zum Zitat Fazel S, Gulati G, Linsell L, et al.: Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine 6:e1000120, 2009. Fazel S, Gulati G, Linsell L, et al.: Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine 6:e1000120, 2009.
13.
Zurück zum Zitat Fountoulakis KN, Leucht S, Kaprinis GS: Personality disorders and violence. Current Opinion in Psychiatry 21:84–92, 2008.CrossRefPubMed Fountoulakis KN, Leucht S, Kaprinis GS: Personality disorders and violence. Current Opinion in Psychiatry 21:84–92, 2008.CrossRefPubMed
14.
Zurück zum Zitat Grant BF, Chou SP, Goldstein RB, et al.: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 69:533–545, 2008.CrossRefPubMed Grant BF, Chou SP, Goldstein RB, et al.: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 69:533–545, 2008.CrossRefPubMed
15.
Zurück zum Zitat Zanarini MC, Frankenburg FR, Reich DB, et al.: Violence in the lives of adult borderline patients. Journal of Nervous and Mental Disease 187:65–71, 1999.CrossRefPubMed Zanarini MC, Frankenburg FR, Reich DB, et al.: Violence in the lives of adult borderline patients. Journal of Nervous and Mental Disease 187:65–71, 1999.CrossRefPubMed
16.
Zurück zum Zitat Goodman M, New A: Impulsive aggression in borderline personality disorder. Current Psychiatry Reports 2:56–61, 2000.CrossRefPubMed Goodman M, New A: Impulsive aggression in borderline personality disorder. Current Psychiatry Reports 2:56–61, 2000.CrossRefPubMed
17.
Zurück zum Zitat de Barros DM, de Padua SA: Association between personality disorder and violent behavior pattern. Forensic Science International 179:19–22, 2008.CrossRefPubMed de Barros DM, de Padua SA: Association between personality disorder and violent behavior pattern. Forensic Science International 179:19–22, 2008.CrossRefPubMed
18.
Zurück zum Zitat Nickel MK, Nickel C, Mitterlehner FO, et al.: Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. Journal of Clinical Psychiatry 65:1515–1519, 2004.CrossRefPubMed Nickel MK, Nickel C, Mitterlehner FO, et al.: Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. Journal of Clinical Psychiatry 65:1515–1519, 2004.CrossRefPubMed
19.
Zurück zum Zitat Raine A: Features of borderline personality and violence. Journal of Clinical Psychology 49:277–281, 1993.CrossRefPubMed Raine A: Features of borderline personality and violence. Journal of Clinical Psychology 49:277–281, 1993.CrossRefPubMed
20.
Zurück zum Zitat Swartz MS, Swanson JW, Hiday VA, et al.: Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. American Journal of Psychiatry 155:226–231, 1998.PubMed Swartz MS, Swanson JW, Hiday VA, et al.: Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. American Journal of Psychiatry 155:226–231, 1998.PubMed
21.
Zurück zum Zitat Latalova K: Bipolar disorder and aggression. International Journal of Clinical Practice 63:889–899, 2009.CrossRefPubMed Latalova K: Bipolar disorder and aggression. International Journal of Clinical Practice 63:889–899, 2009.CrossRefPubMed
22.
Zurück zum Zitat Coid J, Yang M, Roberts A, et al.: Violence and psychiatric morbidity in the national household population of Britain: public health implications. British Journal of Psychiatry 189:12–19, 2006.CrossRefPubMed Coid J, Yang M, Roberts A, et al.: Violence and psychiatric morbidity in the national household population of Britain: public health implications. British Journal of Psychiatry 189:12–19, 2006.CrossRefPubMed
23.
Zurück zum Zitat Howard RC, Huband N, Duggan C, et al.: Exploring the link between personality disorder and criminality in a community sample. Journal of Personality Disorders 22:589–603, 2008.CrossRefPubMed Howard RC, Huband N, Duggan C, et al.: Exploring the link between personality disorder and criminality in a community sample. Journal of Personality Disorders 22:589–603, 2008.CrossRefPubMed
24.
Zurück zum Zitat Elbogen EB, Johnson SC: The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 66:152–161, 2009.CrossRefPubMed Elbogen EB, Johnson SC: The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 66:152–161, 2009.CrossRefPubMed
25.
Zurück zum Zitat Soloff PH, George A, Nathan RS, et al.: Progress in pharmacotherapy of borderline disorders. A double- blind study of amitriptyline, haloperidol, and placebo. Archives of General Psychiatry 43:691–697, 1986. Soloff PH, George A, Nathan RS, et al.: Progress in pharmacotherapy of borderline disorders. A double- blind study of amitriptyline, haloperidol, and placebo. Archives of General Psychiatry 43:691–697, 1986.
26.
Zurück zum Zitat Soloff PH, Cornelius J, George A, et al.: Efficacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry 50:377–385, 1993.PubMed Soloff PH, Cornelius J, George A, et al.: Efficacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry 50:377–385, 1993.PubMed
27.
Zurück zum Zitat Simpson EB, Yen S, Costello E, et al.: Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry 65:379–385, 2004.CrossRefPubMed Simpson EB, Yen S, Costello E, et al.: Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry 65:379–385, 2004.CrossRefPubMed
28.
Zurück zum Zitat Rinne T, van den BW, Wouters L, et al.: SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry 159:2048–2054, 2002. Rinne T, van den BW, Wouters L, et al.: SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry 159:2048–2054, 2002.
29.
Zurück zum Zitat Nickel MK, Muehlbacher M, Nickel C, et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. American Journal of Psychiatry 163:833–838, 2006.CrossRefPubMed Nickel MK, Muehlbacher M, Nickel C, et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. American Journal of Psychiatry 163:833–838, 2006.CrossRefPubMed
30.
Zurück zum Zitat Soler J, Pascual JC, Campins J, et al.: Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. American Journal of Psychiatry 162:1221–1224, 2005.CrossRefPubMed Soler J, Pascual JC, Campins J, et al.: Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. American Journal of Psychiatry 162:1221–1224, 2005.CrossRefPubMed
31.
Zurück zum Zitat Pascual JC, Oller S, Soler J, et al.: Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services. Journal of Clinical Psychiatry 65:1281–1282, 2004.CrossRefPubMed Pascual JC, Oller S, Soler J, et al.: Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services. Journal of Clinical Psychiatry 65:1281–1282, 2004.CrossRefPubMed
32.
Zurück zum Zitat Bellino S, Paradiso E, Bogetto F: Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study. Journal of Clinical Psychiatry 67:1042–1046, 2006.CrossRefPubMed Bellino S, Paradiso E, Bogetto F: Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study. Journal of Clinical Psychiatry 67:1042–1046, 2006.CrossRefPubMed
33.
Zurück zum Zitat Perrella C, Carrus D, Costa E, et al.: Quetiapine for the treatment of borderline personality disorder; an open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:158–163, 2007.CrossRefPubMed Perrella C, Carrus D, Costa E, et al.: Quetiapine for the treatment of borderline personality disorder; an open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:158–163, 2007.CrossRefPubMed
34.
Zurück zum Zitat Van den Eynde F, Senturk V, Naudts K, et al.: Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. Journal of Clinical Psychopharmacology 28:147–155, 2008.CrossRefPubMed Van den Eynde F, Senturk V, Naudts K, et al.: Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. Journal of Clinical Psychopharmacology 28:147–155, 2008.CrossRefPubMed
35.
Zurück zum Zitat Chengappa KN, Ebeling T, Kang JS, et al.: Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry 60:477–484, 1999.PubMed Chengappa KN, Ebeling T, Kang JS, et al.: Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry 60:477–484, 1999.PubMed
36.
Zurück zum Zitat Rocca P, Marchiaro L, Cocuzza E, et al.: Treatment of borderline personality disorder with risperidone. Journal of Clinical Psychiatry 63:241–244, 2002.PubMed Rocca P, Marchiaro L, Cocuzza E, et al.: Treatment of borderline personality disorder with risperidone. Journal of Clinical Psychiatry 63:241–244, 2002.PubMed
37.
Zurück zum Zitat Tritt K, Nickel C, Lahmann C, et al.: Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. Journal of Psychopharmacology 19:287–291, 2005.CrossRefPubMed Tritt K, Nickel C, Lahmann C, et al.: Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. Journal of Psychopharmacology 19:287–291, 2005.CrossRefPubMed
38.
Zurück zum Zitat Nickel MK, Nickel C, Kaplan P, et al.: Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biological Psychiatry 57:495–499, 2005.CrossRefPubMed Nickel MK, Nickel C, Kaplan P, et al.: Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biological Psychiatry 57:495–499, 2005.CrossRefPubMed
39.
Zurück zum Zitat Frankenburg FR, Zanarini MC: Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. Journal of Clinical Psychiatry 63:442–446, 2002.PubMed Frankenburg FR, Zanarini MC: Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. Journal of Clinical Psychiatry 63:442–446, 2002.PubMed
40.
Zurück zum Zitat Simeon D, Baker B, Chaplin W, et al.: An open-label trial of divalproex extended-release in the treatment of borderline personality disorder. CNS Spectrums 12:439–443, 2007.PubMed Simeon D, Baker B, Chaplin W, et al.: An open-label trial of divalproex extended-release in the treatment of borderline personality disorder. CNS Spectrums 12:439–443, 2007.PubMed
41.
Zurück zum Zitat Zanarini MC, Frankenburg FR: Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry 160:167–169, 2003.CrossRefPubMed Zanarini MC, Frankenburg FR: Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry 160:167–169, 2003.CrossRefPubMed
42.
Zurück zum Zitat Links PS, Heslegrave R, Villella J: Psychopharmacological management of personality disorders: an outcome focused model. In: Silk KR (Ed) Biology of personality disorders. Washington, DC, American Psychiatric Press, pp. 93–127, 1998. Links PS, Heslegrave R, Villella J: Psychopharmacological management of personality disorders: an outcome focused model. In: Silk KR (Ed) Biology of personality disorders. Washington, DC, American Psychiatric Press, pp. 93–127, 1998.
43.
Zurück zum Zitat Soloff PH: Algorithm for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic 62:195–214, 1998.PubMed Soloff PH: Algorithm for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic 62:195–214, 1998.PubMed
44.
Zurück zum Zitat Stevenson J, Meares R: An outcome study of psychotherapy for patients with borderline personality disorder. American Journal of Psychiatry 149:358–362, 1992.PubMed Stevenson J, Meares R: An outcome study of psychotherapy for patients with borderline personality disorder. American Journal of Psychiatry 149:358–362, 1992.PubMed
45.
Zurück zum Zitat Meares R, Stevenson J, Comerford A: Psychotherapy with borderline patients, I: a comparison between treated and untreated cohorts. Australian and New Zealand Journal of Psychiatry 33:467–472, 1999.PubMed Meares R, Stevenson J, Comerford A: Psychotherapy with borderline patients, I: a comparison between treated and untreated cohorts. Australian and New Zealand Journal of Psychiatry 33:467–472, 1999.PubMed
46.
Zurück zum Zitat Clarkin JF, Foelsch P, Levy KN et al.: The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioural change. The Journal of Personality Disorders 15:487–495, 2001.CrossRef Clarkin JF, Foelsch P, Levy KN et al.: The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioural change. The Journal of Personality Disorders 15:487–495, 2001.CrossRef
47.
Zurück zum Zitat Bateman A, Fonagy P: The effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American Journal of Psychiatry 156:1563–1569, 1999.PubMed Bateman A, Fonagy P: The effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American Journal of Psychiatry 156:1563–1569, 1999.PubMed
48.
Zurück zum Zitat Bateman A, Fonagy P: Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-months follow up. American Journal of Psychiatry 158:36–42, 2001.CrossRefPubMed Bateman A, Fonagy P: Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-months follow up. American Journal of Psychiatry 158:36–42, 2001.CrossRefPubMed
49.
Zurück zum Zitat Beck AT, Freeman AM: Cognitive therapy of personality disorders. New York, Guilford, 1990. Beck AT, Freeman AM: Cognitive therapy of personality disorders. New York, Guilford, 1990.
50.
Zurück zum Zitat Davidson KA, Tyrer P: Cognitive therapy for antisocial and borderline personality disorders: single case study series. British Journal of Clinical Psychology 35:413–429, 1996.PubMed Davidson KA, Tyrer P: Cognitive therapy for antisocial and borderline personality disorders: single case study series. British Journal of Clinical Psychology 35:413–429, 1996.PubMed
51.
Zurück zum Zitat Tyrer P, Tom B, Byford S, et al.: Differential effects of manual assisted cognitive behaviour therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. The Journal of Personality Disorders 4:161–172, 2004. Tyrer P, Tom B, Byford S, et al.: Differential effects of manual assisted cognitive behaviour therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. The Journal of Personality Disorders 4:161–172, 2004.
52.
Zurück zum Zitat Davidson K, Norrie JA, Tyrer P: The effectiveness of cognitive behavioral therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. The Journal of Personality Disorders 20:450–465, 2006.CrossRef Davidson K, Norrie JA, Tyrer P: The effectiveness of cognitive behavioral therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. The Journal of Personality Disorders 20:450–465, 2006.CrossRef
53.
Zurück zum Zitat Linehan MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, Guilford, 1993. Linehan MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, Guilford, 1993.
54.
Zurück zum Zitat Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL: Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry 48:1060–1064, 1991.PubMed Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL: Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry 48:1060–1064, 1991.PubMed
55.
Zurück zum Zitat Linehan MM, Tutek DA, Heard HL, Armstrong HE: Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. American Journal of Psychiatry 151:1771–1776, 1994.PubMed Linehan MM, Tutek DA, Heard HL, Armstrong HE: Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. American Journal of Psychiatry 151:1771–1776, 1994.PubMed
56.
Zurück zum Zitat Linehan MM, Schmidt H III, Dimeff LA, Craft JC, Kanter J, Comtois KA: Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions 8:279–292, 1999.CrossRefPubMed Linehan MM, Schmidt H III, Dimeff LA, Craft JC, Kanter J, Comtois KA: Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions 8:279–292, 1999.CrossRefPubMed
57.
Zurück zum Zitat Linehan MM, Heard HL, Armstrong HE: Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry 50:971–974, 1993.PubMed Linehan MM, Heard HL, Armstrong HE: Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry 50:971–974, 1993.PubMed
58.
Zurück zum Zitat Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N: Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry. 63:757–766, 2006.CrossRefPubMed Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N: Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry. 63:757–766, 2006.CrossRefPubMed
59.
Zurück zum Zitat Binks CA, Fenton M, McCarthy L et al.: Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews 1:CD005653, 2006. Binks CA, Fenton M, McCarthy L et al.: Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews 1:CD005653, 2006.
60.
Zurück zum Zitat Nose M, Cipriani A, Biancosino B et al.: Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. International Clinical Psychopharmacology 21:345–353, 2006.CrossRefPubMed Nose M, Cipriani A, Biancosino B et al.: Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. International Clinical Psychopharmacology 21:345–353, 2006.CrossRefPubMed
61.
Zurück zum Zitat Herpertz SC, Zanarini M, Schulz CS et al.: World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World Journal of Biological Psychiatry 8:212–244, 2007.CrossRefPubMed Herpertz SC, Zanarini M, Schulz CS et al.: World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World Journal of Biological Psychiatry 8:212–244, 2007.CrossRefPubMed
62.
Zurück zum Zitat Soloff PH, George A, Nathan RS, et al.: Paradoxical effects of amitriptyline on borderline patients. American Journal of Psychiatry 143:1603–1605, 1986.PubMed Soloff PH, George A, Nathan RS, et al.: Paradoxical effects of amitriptyline on borderline patients. American Journal of Psychiatry 143:1603–1605, 1986.PubMed
63.
Zurück zum Zitat Soloff PH, George A, Nathan RS, et al.: Behavioral dyscontrol in borderline patients treated with amitriptyline. Psychopharmacology Bulletin 23:177–181, 1987.PubMed Soloff PH, George A, Nathan RS, et al.: Behavioral dyscontrol in borderline patients treated with amitriptyline. Psychopharmacology Bulletin 23:177–181, 1987.PubMed
64.
Zurück zum Zitat Linehan MM, McDavid JD, Brown MZ, et al.: Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry 69:999–1005, 2008.CrossRefPubMed Linehan MM, McDavid JD, Brown MZ, et al.: Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry 69:999–1005, 2008.CrossRefPubMed
65.
Zurück zum Zitat Pascual JC, Soler J, Puigdemont D, et al.: Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. Journal of Clinical Psychiatry 69:603–608, 2008.CrossRefPubMed Pascual JC, Soler J, Puigdemont D, et al.: Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. Journal of Clinical Psychiatry 69:603–608, 2008.CrossRefPubMed
66.
Zurück zum Zitat Lipman RS, Covi L, Shapiro AK: The Hopkins symptom checklist (HSCL)––factors derived from the HSCL-90. Journal of Affective Disorders 1:9–24, 1979.CrossRefPubMed Lipman RS, Covi L, Shapiro AK: The Hopkins symptom checklist (HSCL)––factors derived from the HSCL-90. Journal of Affective Disorders 1:9–24, 1979.CrossRefPubMed
67.
Zurück zum Zitat Teicher MH, Glod CA, Aaronson ST, et al.: Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder. Psychopharmacology Bulletin 25:535–549, 1989.PubMed Teicher MH, Glod CA, Aaronson ST, et al.: Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder. Psychopharmacology Bulletin 25:535–549, 1989.PubMed
68.
Zurück zum Zitat Hollander E, Allen A, Lopez RP, et al.: A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry 62:199–203, 2001.PubMed Hollander E, Allen A, Lopez RP, et al.: A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry 62:199–203, 2001.PubMed
Metadaten
Titel
Aggression in Borderline Personality Disorder
verfasst von
K. Látalová
J. Praško
Publikationsdatum
01.09.2010
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 3/2010
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-010-9133-3

Weitere Artikel der Ausgabe 3/2010

Psychiatric Quarterly 3/2010 Zur Ausgabe

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.